10 Most-Advertised Brand-Name Drugs

AUGUST 27, 2015
Allison Gilchrist, Associate Editor

2.      Lyrica ($228.9 million spent on advertising)

Pfizer’s total ad spending for Lyrica (pregabalin) in 2014 was split evenly between the drug’s 2 indications: fibromyalgia ($123.1 million) and diabetic neuropathy ($105.7 million).
Lyrica is a preferred non-opioid option for both nociceptive and neuropathic pain patients.
The drug generated $5.2 billion in sales last year and is ranked last on the top 10 list of best-selling brand-name drugs so far in 2015.